|
Secondary prevention
Citations 541-550 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Investigations and Reports
New Insights Into the Progression of Aortic Stenosis : Implications for Secondary Prevention
- Sanjeev Palta, Anita M. Pai, Kanwaljit S. Gill, and Ramdas G. Pai
Circulation 2000;101:2497-2502
[Abstract]
[Full text]
- Clinical Investigations and Reports
Oral L-Arginine in Patients With Coronary Artery Disease on Medical Management
- Arnon Blum, Londa Hathaway, Rita Mincemoyer, William H. Schenke, Martha Kirby, Gyorgy Csako, Myron A. Waclawiw, Julio A. Panza, and Richard O. Cannon, III
Circulation 2000;101:2160-2164
[Abstract]
[Full text]
- Clinical Investigations and Reports
The Apolipoprotein  4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study
- Lars Ulrik Gerdes, Christian Gerdes, Kari Kervinen, Markku Savolainen, Ib Christian Klausen, Peter Steen Hansen, Y. Antero Kesäniemi, and Ole Færgeman
Circulation 2000;101:1366-1371
[Abstract]
[Full text]
- Clinical Investigations and Reports
Canadian Implantable Defibrillator Study (CIDS) : A Randomized Trial of the Implantable Cardioverter Defibrillator Against Amiodarone
- Stuart J. Connolly, Michael Gent, Robin S. Roberts, Paul Dorian, Denis Roy, Robert S. Sheldon, L. Brent Mitchell, Martin S. Green, George J. Klein, and Bernard O’Brien
Circulation 2000;101:1297-1302
[Abstract]
[Full text]
- Circulation Electronic Pages
Chlamydia pneumoniae in Coronary Artery Disease
- Enrique Gurfinkel, Gerardo Bozovich, and Branco Mautner
Circulation 2000;101:e95
[Full text]
- Clinical Investigations and Reports
Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease
- Randall S. Stafford
Circulation 2000;101:1097-1101
[Abstract]
[Full text]
- Cardiovascular Drugs
Aspirin
- Eric H. Awtry and Joseph Loscalzo
Circulation 2000;101:1206-1218
[Full text]
- Circulation Electronic Pages
The Nature of the Statins • Response
- Peter H. Jones and Curt D. Furberg
Circulation 2000;101:e89
[Full text]
- AHA Science Advisory
Resistance Exercise in Individuals With and Without Cardiovascular Disease : Benefits, Rationale, Safety, and PrescriptionAn Advisory From the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association
- Michael L. Pollock, Barry A. Franklin, Gary J. Balady, Bernard L. Chaitman, Jerome L. Fleg, Barbara Fletcher, Marian Limacher, Ileana L. Piña, Richard A. Stein, Mark Williams, and Terry Bazzarre
Circulation 2000;101:828-833
[Full text]
- Circulation Electronic Pages
Synthetic Inhibitors of Platelet Glycoprotein IIb/IIIa in Clinical Development
- Marc Verstraete
Circulation 2000;101:e76-80e
[Abstract]
[Full text]
|
|
